CrowdStrike: With Growth Ready to Accelerate, Is It Time to Buy the Stock?

CrowdStrike reported mixed Q2 FY26 results, with revenue up 21% to $1.17 billion and adjusted EPS of $0.93 beating consensus, yet annual recurring revenue (ARR) growth decelerated to 20%. Despite this, the company projects ARR growth to accelerate significantly to at least 40% in the second half of fiscal 2026, driven by strength in AI solutions and the Falcon Flex licensing model. While this outlook and robust cash flow are positive, the stock's current valuation of nearly 22x forward price-to-sales suggests that much of this future optimism is already priced into the shares.

Analysis

CrowdStrike's fiscal Q2 2026 results present a mixed picture, characterized by decelerating current growth juxtaposed with a highly optimistic forward outlook. While revenue grew 21% year-over-year to $1.17 billion, slightly beating consensus, the critical annual recurring revenue (ARR) growth slowed to 20% from 22% in the prior quarter, continuing a multi-quarter deceleration trend. However, the key catalyst for the stock is management's projection for ARR growth to reaccelerate to at least 40% in the second half of fiscal 2026. This forecast is underpinned by the success of its Falcon Flex licensing model, which has secured over 1,000 customers with an average ARR exceeding $1 million, and strong momentum in next-gen security modules, which collectively represent nearly $1.6 billion in ARR. Despite these positives and an adjusted EPS beat at $0.93, the company's Q3 revenue guidance of $1.21 billion to $1.22 billion fell just short of analyst expectations. The primary concern for investors is the stock's demanding valuation, trading at a forward price-to-sales multiple of nearly 22, which suggests the market has already priced in a flawless execution of this ambitious growth reacceleration.

Key Decisions for Investors

• Given the stock's forward price-to-sales multiple of nearly 22, investors should recognize that the optimistic guidance for 40% ARR growth is largely priced in, creating significant downside risk if the company fails to meet these elevated expectations.
• Investors should closely monitor the company's ability to execute on its aggressive H2 FY26 ARR growth forecast, paying specific attention to the uptake of the Falcon Flex model and the growth trajectory of next-gen modules as primary drivers.
• The slightly weak Q3 revenue guidance, which fell short of analyst consensus, warrants a cautious stance, and it may be prudent to await concrete evidence of the guided ARR reacceleration before initiating or adding to a position.